Linker Information
General Information of This Linker
| Linker ID |
LIN0KORZE
|
|||||
|---|---|---|---|---|---|---|
| Linker Name |
ADC 1-12 linker
|
|||||
| Antibody-Linker Relation |
Cleavable
|
|||||
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
ADC1-12 [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Maximum inhibition efficiency (MIE) |
5.76%
|
Low PTK7 expression (PTK7 +) | ||
| Method Description |
Cells were then treated with a 10-points titration of compounds, including ADC1-1, ADC1-11,ADC1-4,ADC1-2 and ADC1-12. The plates were incubated for 7 days at 37°C, 5% CO2. Next, 50 uL of Cell-Titer- Glo reagent was added to each well. The mixture was mixed on an orbitalshaker for 10 mins to allow cell lysis.
|
||||
| In Vitro Model | Lung adenocarcinoma | A-549 cells | CVCL_0023 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Maximum inhibition efficiency (MIE) |
86.04%
|
High PTK7 expression (PTK7 +++) | ||
| Method Description |
Cells were then treated with a 10-points titration of compounds, including ADC1-1, ADC1-11,ADC1-4,ADC1-2 and ADC1-12. The plates were incubated for 7 days at 37°C, 5% CO2. Next, 50 uL of Cell-Titer- Glo reagent was added to each well. The mixture was mixed on an orbitalshaker for 10 mins to allow cell lysis.
|
||||
| In Vitro Model | Ovarian serous adenocarcinoma | OVCAR-3 cells | CVCL_0465 | ||
| Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal Effective Concentration (EC50) |
39.39 nM
|
High PTK7 expression (PTK7 +++) | ||
| Method Description |
Cells were then treated with a 10-points titration of compounds, including ADC1-1, ADC1-11,ADC1-4,ADC1-2 and ADC1-12. The plates were incubated for 7 days at 37°C, 5% CO2. Next, 50 uL of Cell-Titer- Glo reagent was added to each well. The mixture was mixed on an orbitalshaker for 10 mins to allow cell lysis.
|
||||
| In Vitro Model | Ovarian serous adenocarcinoma | OVCAR-3 cells | CVCL_0465 | ||
| Experiment 4 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal Effective Concentration (EC50) | > 200 nM | Low PTK7 expression (PTK7 +) | ||
| Method Description |
Cells were then treated with a 10-points titration of compounds, including ADC1-1, ADC1-11,ADC1-4,ADC1-2 and ADC1-12. The plates were incubated for 7 days at 37°C, 5% CO2. Next, 50 uL of Cell-Titer- Glo reagent was added to each well. The mixture was mixed on an orbitalshaker for 10 mins to allow cell lysis.
|
||||
| In Vitro Model | Lung adenocarcinoma | A-549 cells | CVCL_0023 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.